Drugs for chronic obstructive pulmonary disease.
作者信息
Jenkins Christine
机构信息
Senior staff specialist, Department of Thoracic Medicine, Concord Hospital.
出版信息
Aust Prescr. 2017 Feb;40(1):15-19. doi: 10.18773/austprescr.2017.003. Epub 2017 Feb 1.
Abstract
摘要
相似文献
1
Drugs for chronic obstructive pulmonary disease.
Aust Prescr. 2017 Feb;40(1):15-19. doi: 10.18773/austprescr.2017.003. Epub 2017 Feb 1.
2
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int. 2016 Nov;25(176):272-277.
3
Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007033. doi: 10.1002/14651858.CD007033.pub2.
4
Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Respir Med. 2017 Sep;130:75-84. doi: 10.1016/j.rmed.2017.07.012. Epub 2017 Jul 19.
5
Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
JAMA. 2014 Sep 17;312(11):1114-21. doi: 10.1001/jama.2014.11432.
6
Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Epub 2011 Jun 30.
7
The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease.
Tuberc Respir Dis (Seoul). 2016 Oct;79(4):241-247. doi: 10.4046/trd.2016.79.4.241. Epub 2016 Oct 5.
8
Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Epub 2010 May 21.
9
Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.
Drugs Aging. 2003;20(3):209-28. doi: 10.2165/00002512-200320030-00005.
10
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.
引用本文的文献
1
Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges.
Geriatrics (Basel). 2024 Mar 7;9(2):34. doi: 10.3390/geriatrics9020034.
2
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.
BMJ Open Respir Res. 2023 Mar;10(1). doi: 10.1136/bmjresp-2022-001508.
3
4
Managing the overlap of asthma and chronic obstructive pulmonary disease.
Aust Prescr. 2020 Feb;43(1):7-11. doi: 10.18773/austprescr.2020.002. Epub 2020 Feb 3.
本文引用的文献
1
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15.
2
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
N Engl J Med. 2016 May 12;374(19):1811-21. doi: 10.1056/NEJMoa1505971.
3
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7.
4
Update on medicines for smoking cessation.
Aust Prescr. 2015 Aug;38(4):106-11. doi: 10.18773/austprescr.2015.038. Epub 2015 Aug 3.
5
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.
Thorax. 2016 Feb;71(2):118-25. doi: 10.1136/thoraxjnl-2015-207021. Epub 2015 Nov 19.
6
Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med. 2015 Aug 15;192(4):523-5. doi: 10.1164/rccm.201502-0235LE.
7
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
Lancet Respir Med. 2015 Jun;3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X. Epub 2015 Apr 12.
8
A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD.
Chest. 2015 Aug;148(2):397-407. doi: 10.1378/chest.15-0084.
9
Inhaled corticosteroids in COPD: the clinical evidence.
Eur Respir J. 2015 Feb;45(2):525-37. doi: 10.1183/09031936.00128914. Epub 2014 Dec 23.
10
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives.
Br J Clin Pharmacol. 2015 May;79(5):695-708. doi: 10.1111/bcp.12545.
Zotero 插件